跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GEMZAR 200MG LYPH.VIAL 5ML - SFDA Drug Approval Details
Approvals
/
SFDA
/
GEMZAR 200MG LYPH.VIAL 5ML
Authorized
NCE
GEMZAR 200MG LYPH.VIAL 5ML
Unknown
🇸🇦 Saudi Food and Drug Authority
Approval Date
N/A
Approval ID
c6aafe9d6e5a6e35
Company
Unknown
Type
NCE
Approval Details
Approval Id
c6aafe9d6e5a6e35
Drug Approval Sfda Name
GEMZAR 200MG LYPH.VIAL 5ML
Trade Name
GEMZAR 200MG LYPH.VIAL 5ML
Generic Name
GEMCITABINE
Register Number
1-5396-19
Register Year
2019
Drug Type
NCE
Route Of Administration
Intravenous use
Package Type
Vial
Package Size
1
Size
10
Size Unit
ml
Legal Status
Prescription
Authorization Status
Valid
Marketing Status
Marketed
Product Control
Uncontrolled
Storage Conditions
store below 30°c
Shelf Life
36 Months
Distribution Site
Hospital
Description Code
7000000572-40-100000073859
Price
142.6
Active Ingredients
Authorized
Quick Info
Agency
SFDA
Country
🇸🇦
Approval ID
c6aafe9d6e5a6e35
Type
NCE
Back to SFDA Approvals